Physician profile
Tomer D Mann
NPI 1487381604
$5,631.64
in general payments reported to CMS, 2019-2025
7 companies · $2,799 in 2025
The $2,799 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $75.66 · 2024: $2,757 · 2025: $2,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940 · Grant: $1,446 · Travel and Lodging: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.60 |
| Grant | $1,446.16 |
| Travel and Lodging | $1,245.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,633.58 | 2024-2025 | Micra, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Boston Scientific Corporation | $853.72 | 2024-2025 | Electrophysiology Cable, Farapulse, Emblem Mri S-Icd |
| Biosense Webster, INC. | $596.05 | 2024 | Carto 3, Nuvision Ice Catheter |
| Biotronik INC. | $386.88 | 2023-2025 | Acticor 7 Vr-T Dx, Selectra, Plexa Promri |
| Abbott Laboratories | $110.76 | 2024-2025 | Ensite, Perclose Prostyle |
| Cordis US Corp. | $26.41 | 2025 | Mynx Control Venous |
| Teleflex LLC | $24.24 | 2025 | Piggyback |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomer Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.